EP-1354: Meta analysis of carbon ion therapy prostatic cancer

[Neoadjuvant therapy for prostatic cancer].

Neoadjuvant therapy for prostatic cancer might be important to increase cure rates of the disease and preservability of the organs. There were 43 cases in a period of 1975-1990 in which total prostatectomy were performed after neoadjuvant therapy. According to the clinical stage, there were 14 cases in B, 23 in C, 4 in D1 and 2 in D2. The median duration of neoadjuvant therapy was 4 months. Cli...

Meta-analysis of Incidence of Brain Cancer Among Aircrew

Introduction: Previous studies on Brain and other Nervous System Cancers (BNSC) and aircrew have shown inconsistent results, possibly due to their relatively small sample sizes; therefore, the current study aimed to increase the precision of risk estimates.Methods: Systematic searches of PubMed and Embase for pertinent studies up to August 2016 were perfo...

Steroid response to therapy in prostatic cancer.

IFTEEN years have passed since Huggins and F Hodgeslz first demonstrated the marked response of patients with prostatic cancer to castration and estrogen therapy. This response has become thoroughly established. Patients eventually relapse from this treatment, and there is a growing body 01 evidence that the relapse is frequently associated with increased production of adrenal androgen. It is n...

Laser Therapy in Localized Prostatic Cancer

Cost analysis of radiotherapy, carbon ion therapy, proton therapy and BNCT in Japan.

The purpose of this study was to estimate the financial costs to start BNCT as a clinical treatment in a hospital. To evaluate more accurate data on the precise costs of BNCT, we analyzed the costs of conventional radiotherapy, carbon ion and proton therapy and compare them to BNCT. An aggregate cost calculation of accelerator, buildings, equipments and staff requirements was performed.